Sage Therapeutics, Inc. (SAGE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sage Therapeutics, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.82x | -2.39x | -4.49x | -5.54x | 7.42x | -5.64x |
| P/B Ratio | 0.71x | 1.62x | 1.81x | 1.44x | 2.17x | 3.88x |
| P/S Ratio | 8.00x | 15.00x | 294.29x | 395.66x | 4.04x | 534.32x |
| Profitability | ||||||
| Gross Margin | 77.1% | 97.5% | 89.4% | 91.2% | 99.9% | 94.2% |
| Operating Margin | -1048.3% | -670.7% | -7116.7% | -7306.7% | 53.5% | -10310.5% |
| Net Margin | -971.5% | -626.3% | -6547.8% | -7146.9% | 54.4% | -9466.4% |
| EBITDA Margin | -992.9% | -630.5% | -7102.1% | -7240.4% | 56.2% | -10277.2% |
| Liquidity | ||||||
| Current Ratio | 7.42x | 10.51x | 12.82x | 21.14x | 31.58x | 9.23x |
| Quick Ratio | 7.42x | 10.51x | 13.47x | 21.14x | 31.58x | 9.23x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.01x | 0.01x | 0.01x | 0.01x | 0.04x |
YoY = year-over-year change. Source: FMP..